ALEXANDRIA DATTILO: Open Payments
NPI 1497493845 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,672 in 169 payments from 20 companies in 2025. Trend: 2023 $1,167 · 2024 $1,254 · 2025 $2,672
Food & beverage: $2,660Education: $12
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 26 | $325 |
| Alkermes, Inc. | 14 | $321 |
| Otsuka America Pharmaceutical, Inc. | 17 | $302 |
| Neurocrine BioSciences, Inc. | 15 | $268 |
| Vanda Pharmaceuticals Inc. | 13 | $219 |
| Teva Pharmaceuticals USA, Inc. | 11 | $211 |
| Janssen Pharmaceuticals, Inc | 17 | $190 |
| Axsome Therapeutics, Inc. | 18 | $178 |
| ABBVIE INC. | 12 | $156 |
| Lundbeck LLC | 7 | $140 |
Products named: Qelbree, ARISTADA, INGREZZA, REXULTI, FANAPT, AUSTEDO XR, Auvelity, VRAYLAR.
Industry payments across WI — which companies pay providers there.
